我国中药出口遭遇的技术性贸易壁垒法律问题研究

发布时间：2018-06-30 09:07

本文选题：技术性贸易壁垒 + 技术法规　；参考：《复旦大学》2012年硕士论文

【摘要】：作为中华民族传统文化精华的中医药,在保障我国古代人民的繁衍昌盛以及文化交流方面做出了不可磨灭的作用。但到了近代,作为我国独创的中医药,由于频频遭遇国外市场的贸易壁垒,在出口国外市场方面遭遇了极大的障碍,造成出口额较少,国际市场占有率较低的窘境。本文分四个章节来分别阐述了wTO技术性贸易壁垒规则,我国中药出口遭遇的技术性贸易壁垒以及从法律角度的应对策略。其中第一章阐述了我国中药出口遭遇的技术性贸易壁垒,包括我国中药出口遭遇的技术性贸易壁垒的主要形式以及对我国中药出口造成的影响.介绍了wTO规则中有关技术性贸易壁垒的法律规则,主要包括《技术性贸易壁垒协议》和《实施卫生和动植物检疫措施协议》；在本文第二章详细介绍了我国和我国主要出口市场的植物药监管体制,鉴于欧盟市场和美国市场具有巨大的市场容量和较为严格的植物药管理体系,本文着重分析了欧盟的《传统植物药注册程序指令》以及美国植物药的上市申请方式；本文第三章主要阐述了中药技术性贸易壁垒的影响和成因分析,并分析了我国中药产业存在的主要问题；最后一章阐述了应对中药技术性贸易壁垒的策略,重点从法律角度给出了自己的建议。
[Abstract]:As the essence of Chinese traditional culture, Chinese medicine plays an indelible role in ensuring the prosperity of ancient Chinese people and cultural exchange. But in modern times, as the original Chinese medicine of our country, because of frequently encountered the foreign market trade barrier, has encountered the enormous barrier in the export foreign market aspect, causes the export volume to be small, the international market share is low the predicament. This article is divided into four chapters to explain the rules of WTO TBT, the TBT encountered by Chinese traditional medicine export and the countermeasures from the legal point of view. The first chapter describes the technical barriers to trade encountered by Chinese traditional medicine exports, including the main forms of technical trade barriers encountered by Chinese traditional medicine exports and the impact on Chinese traditional medicine exports. This paper introduces the legal rules of technical barriers to trade (TBT) in the WTO rules, including the Agreement on Technical barriers to Trade (TBT) and the Agreement on the implementation of Sanitary and Phytosanitary measures (SPS). In the second chapter of this paper, we introduce in detail the regulatory system of vegetable drugs in our country and our main export markets. In view of the huge market capacity and strict management system of plant drugs in the European Union market and the American market, This paper focuses on the European Union's "traditional Plant Drug Registration procedure Directive" and the application for the listing of American plant drugs. The third chapter mainly describes the impact and causes of the TBT of traditional Chinese medicine. In the last chapter, the strategies to deal with the TBT of traditional Chinese medicine are discussed, and some suggestions are put forward from the point of view of law.
【学位授予单位】：复旦大学
【学位级别】：硕士
【学位授予年份】：2012
【分类号】：D997.1

【参考文献】